King's College London

Curtin University of Technology

Barbara Mulloy

Clive Pete Page

Deirdre Roma Coombe

Warren Charles Kett

Michelle Marguerite Grundy

John Douglas McKenzie

Neville Vincent Richardson

Charles Daniel Bavington

Rebecca Lever

John Douglas Mckenzie

Clive Peter Page

The present invention relates generally to chemical agents useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory including allergic diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites. More particularly, the chemical agents contemplated by the present invention are selected from glycosaminoglycan (GAG) molecules derived from a larger GAG, GAG-like molecules which resemble GAGs in some of their characteristics but may be derived from a larger non-GAG polysaccharide and molecules having a GAG-like composite structure as well as agents which bind to the same sites as GAGs, GAG-like molecules or GAG-like composite molecules. The present invention also provides assays to identify GAG and GAG-like therapeutic agents including GAG-like composite structures as well as analogs, homologs and orthologs thereof.

Therapeutic heparins and their binding to interleukins 4 and 5 and PECAM-1

The invention relates to a product capable of having one or more properties sected from: anti-fouling properties, anti-adhesive properties, anti-inflammatory properties, and wherein said product is obtainable from starfish.

Product from starfish

Growing community of inventors

London, United Kingdom

Barbara Mulloy